<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=314834185700910&amp;ev=PageView&amp;noscript=1">

New Update: Healthcare Costs Increasing by Over 60% in Some States. Will you be impacted?

Learn More

Tax Strategies for Charles River Laboratories International Employees With Concentrated Stock Positions

image-table

For Charles River Laboratories International employees who have experienced significant market appreciation, the thought of rebalancing their portfolio can be daunting. The large embedded capital gains in their holdings often create a powerful disincentive to sell, leading to a 'tax-locked' portfolio. While an investor may have a well-diversified portfolio on the whole, a single, highly appreciated stock can still represent an uncomfortable level of risk. In these situations, the conventional wisdom of simply selling the position is often prohibitively expensive from a tax perspective. However, a little-known but powerful tool—the Section 351 exchange—may offer a strategic and tax-efficient solution.

Consider Michael, a successful professional with a total investment portfolio of $5 million. The majority of his assets are in a broadly diversified mix of mutual funds and exchange traded funds (ETFs). However, his portfolio also includes a single stock position valued at $500,000, which he acquired years ago for $100,000. While this single stock represents only 10% of his total portfolio, its low cost basis and unrealized gain of $400,000 make him hesitant to sell. A sale would trigger a tax bill of roughly $95,200, reducing the capital available for reinvestment and diversification. Michael's situation is common; he understands the importance of diversification, but the tax cost of achieving it feels punitive.

This is precisely the kind of scenario where a Section 351 exchange can provide a strategic advantage. This tax provision, as outlined in the Internal Revenue Code, allows for a tax-deferred transfer of property to a corporation in exchange for its stock, provided certain conditions are met. As Kevin Landis, a finanial advisor with Wealth Enhancement notes, 'A Section 351 exchange could help investors with appreciated assets achieve tax-efficient diversification.'

The core of the strategy is rooted in the tax code itself. IRC Section 351(a) states: “No gain or loss shall be recognized if property is transferred to a corporation by one or more persons solely in exchange for stock in such corporation and immediately after the exchange such person or persons are in control (as defined in section 368(c)) of the corporation.” The gain is not eliminated, but deferred, as the investor's original cost basis carries over to the new corporate shares. This is a critical distinction from a traditional sale.

For the exchange to be valid, two main requirements must be satisfied:

Diversification: The portfolio being transferred must be diversified according to the IRS's 25/50 test. This means no single holding can represent more than 25% of the total value, and the top five holdings cannot exceed 50%. Since Michael's $500,000 single stock position is only 10% of his total $5 million portfolio, his entire portfolio passes this test.

Control: The investor must have at least 80% control of the newly formed corporation immediately following the exchange. In practice, this is often achieved by multiple 'seeding' investors transferring assets at the same time to establish an ETF, or by an investor with a significant enough portfolio acting as the primary seeder of a new fund.

By working with an ETF sponsor that facilitates these exchanges, Michael can transfer his entire $5 million portfolio into a newly formed ETF. He would receive ETF shares in return, and his $400,000 unrealized gain would not be taxed. Within the ETF wrapper, the fund manager could then sell Michael's single stock and reinvest the proceeds into other securities to align with the fund's mandate. Due to the in-kind creation and redemption process of ETFs, this internal rebalancing does not trigger a taxable event for Michael. He has successfully diversified away from his single-stock risk and preserved the full $500,000 of market value.

Tyson Mavar, a Senior Vice President and Financial Advisor with Wealth Enhancement, emphasizes the importance of a holistic approach to these complex strategies. 'For clients with significant embedded gains, the goal is always to optimize after-tax returns,' Mavar says. 'A Section 351 exchange is a prime example of a strategy that, when executed correctly, can help preserve capital that may otherwise be lost to taxes, allowing it to continue working for the client over the long term.'

While the benefits are clear, it's important to acknowledge the limitations. The number of ETFs currently accepting such exchanges is limited, and these funds may have higher expense ratios than their more established counterparts. There's also the risk of an inadvertent tax treatment failure if the rules are not strictly followed. However, for an investor like Michael, the ability to defer a substantial tax bill and gain immediate diversification makes the strategy compelling. It is a powerful tool for advisors to help their clients escape the 'tax-locked' state and realign their portfolios with their long-term financial goals.

Key Resources:

IRC Section 351(a): https://www.law.cornell.edu/uscode/text/26/351

IRS Treasury Regulation 1.351-1(c)(5): This regulation details the diversification test, often referred to as the 25/50 test, which is crucial for the strategy to be valid.

Kitces.com: 'Using Section 351 Exchanges To Tax-Efficiently Reallocate Portfolios' by Ben Henry-Moreland (March 12, 2025). This article provides a comprehensive overview of the strategy's mechanics and use cases.

Cambria Tax Aware ETF (Ticker: TAX): As one of the first ETFs to publicly announce the use of Section 351 exchanges, its prospectus and fund information offer a real-world example of the strategy in practice.

Longview  Advantage ETF (Ticker: EBI): Another example of a new fund launched via Section 351, demonstrating the increasing adoption of this strategy by ETF sponsors.

Other ideas if you own a highly appreciated stock

Featured Video

Articles you may find interesting:

Loading...

- Donating highly appreciated stock to a public charity.

- Contributing appreciated stock to a Donor-Advised Fund (DAF).

- Gifting highly appreciated stock to a family member in a lower tax bracket.

- Upstream gifting of appreciated stock to an older family member for a step-up in basis.

- Using tax-loss harvesting to offset capital gains.

- Entering into a variable prepaid forward contract.

- Reinvesting capital gains into a Qualified Opportunity Fund (QOF).

- Holding the stock until death to receive a step-up in basis for heirs.

What type of retirement savings plan does Charles River Laboratories International offer?

Charles River Laboratories International offers a 401(k) retirement savings plan to its employees.

Does Charles River Laboratories International match employee contributions to the 401(k) plan?

Yes, Charles River Laboratories International provides a matching contribution to employee 401(k) contributions, subject to certain limits.

What is the eligibility requirement to participate in the 401(k) plan at Charles River Laboratories International?

Employees of Charles River Laboratories International are generally eligible to participate in the 401(k) plan after completing a specified period of service.

How can employees of Charles River Laboratories International enroll in the 401(k) plan?

Employees can enroll in the 401(k) plan through the company’s benefits portal or by contacting the HR department at Charles River Laboratories International.

What investment options are available in the 401(k) plan at Charles River Laboratories International?

Charles River Laboratories International offers a variety of investment options in its 401(k) plan, including mutual funds, target-date funds, and other investment vehicles.

Can employees of Charles River Laboratories International take loans against their 401(k) savings?

Yes, Charles River Laboratories International allows employees to take loans against their 401(k) savings, subject to the plan's rules and regulations.

What is the vesting schedule for employer contributions in the 401(k) plan at Charles River Laboratories International?

The vesting schedule for employer contributions at Charles River Laboratories International may vary, but typically follows a graded vesting schedule over several years.

How often can employees of Charles River Laboratories International change their 401(k) contributions?

Employees can change their 401(k) contribution amounts at any time, subject to the plan's guidelines set by Charles River Laboratories International.

Are there any fees associated with the 401(k) plan at Charles River Laboratories International?

Yes, there may be administrative fees associated with the 401(k) plan at Charles River Laboratories International, which are disclosed in the plan documents.

What resources does Charles River Laboratories International provide to help employees manage their 401(k) investments?

Charles River Laboratories International provides educational resources, access to financial advisors, and online tools to help employees manage their 401(k) investments.

With the current political climate we are in it is important to keep up with current news and remain knowledgeable about your benefits.
Update: In 2024, Charles River Laboratories International has announced a significant overhaul of its 401(k) plan, which includes increasing the company match percentage and introducing a new vesting schedule. This change is aimed at improving employee retention and competitive positioning. The update is crucial in the current economic environment where employees are seeking better retirement benefits amid economic uncertainty.
Restructuring Layoffs: Charles River Laboratories announced a workforce reduction in early 2024. The company is consolidating its facilities and focusing on higher-margin services, resulting in layoffs primarily affecting administrative and support roles. This restructuring is part of their broader strategy to streamline operations and reduce costs amidst economic uncertainty.
Charles River Laboratories International Stock Options and RSUs 2022 Stock Options: Charles River Laboratories International granted stock options primarily to executives and senior management. These options typically had a vesting period of 4 years with annual vesting in 25% increments. RSUs: RSUs were awarded to a broader employee base, including senior executives and key employees. These units generally vested over a period of 3 years with a performance component tied to company goals. Availability: Stock options and RSUs were part of the company's broader compensation package to attract and retain top talent, with specific allocations based on role and performance. 2023 Stock Options: Charles River Laboratories International continued to offer stock options, mainly to higher-level executives and employees in strategic roles. The options typically had a 4-year vesting schedule with performance criteria. RSUs: In 2023, Charles River Laboratories International expanded its RSU program to include mid-level management. The vesting schedule remained similar, with a 3-year timeline and performance metrics. Availability: Both stock options and RSUs were used to incentivize employees and align their interests with company performance, with allocation levels varying by position and individual performance. 2024 Stock Options: For 2024, Charles River Laboratories International maintained its stock option program, focusing on key positions and high performers. The vesting schedule continued to be spread over 4 years. RSUs: The RSU program for 2024 included adjustments to address market conditions and employee retention. The vesting period stayed at 3 years, with an increased emphasis on performance-based criteria. Availability: The stock options and RSUs were integral to the company’s compensation strategy, aimed at rewarding contributions and aligning employee interests with the company’s long-term goals.
Charles River Laboratories International offers a range of health benefits designed to support employee well-being. For the years 2022, 2023, and 2024, the company has implemented comprehensive healthcare coverage including medical, dental, and vision insurance. In 2023, Charles River Laboratories introduced a new Health Savings Account (HSA) option for employees, allowing for more flexible contributions and tax advantages. Additionally, the company provides an Employee Assistance Program (EAP) to support mental health and work-life balance. Recent updates also include enhanced telehealth services and expanded coverage for preventive care. In the current economic and political climate, Charles River Laboratories' healthcare offerings play a crucial role in attracting and retaining talent. As the investment landscape evolves, the company's commitment to comprehensive healthcare benefits helps mitigate employee concerns about medical costs and access to care. This focus on health benefits is particularly relevant amid ongoing discussions about healthcare policy reforms and economic fluctuations, which can impact both corporate budgets and employee well-being. As such, Charles River Laboratories' proactive approach to healthcare is an important factor in maintaining employee satisfaction and organizational stability.
New call-to-action

Additional Articles

Check Out Articles for Charles River Laboratories International employees

Loading...

For more information you can reach the plan administrator for Charles River Laboratories International at 251 Ballardvale St. Wilmington, MA 1887; or by calling them at 1-781-222-6000.

https://www.businessinsider.com/ https://www.reuters.com/ https://www.bloomberg.com/asia https://www.marketwatch.com/ http://www.thelayoff.com/ http://www.sec.gov/ http://www.fidelity.com/ http://www.morningstar.com/ http://www.bloomberg.com/ https://www.thelayoff.com/ https://www.businessinsider.com/ https://www.reuters.com/ https://www.bloomberg.com/asia

*Please see disclaimer for more information

Relevant Articles

Check Out Articles for Charles River Laboratories International employees